JP2015534567A5 - - Google Patents

Download PDF

Info

Publication number
JP2015534567A5
JP2015534567A5 JP2015536065A JP2015536065A JP2015534567A5 JP 2015534567 A5 JP2015534567 A5 JP 2015534567A5 JP 2015536065 A JP2015536065 A JP 2015536065A JP 2015536065 A JP2015536065 A JP 2015536065A JP 2015534567 A5 JP2015534567 A5 JP 2015534567A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
compound according
acceptable salt
alkyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015536065A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015534567A (ja
JP6333825B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/070407 external-priority patent/WO2014056755A1/en
Publication of JP2015534567A publication Critical patent/JP2015534567A/ja
Publication of JP2015534567A5 publication Critical patent/JP2015534567A5/ja
Application granted granted Critical
Publication of JP6333825B2 publication Critical patent/JP6333825B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015536065A 2012-10-11 2013-10-01 インドリン Expired - Fee Related JP6333825B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261712317P 2012-10-11 2012-10-11
US61/712,317 2012-10-11
PCT/EP2013/070407 WO2014056755A1 (en) 2012-10-11 2013-10-01 Indolines

Publications (3)

Publication Number Publication Date
JP2015534567A JP2015534567A (ja) 2015-12-03
JP2015534567A5 true JP2015534567A5 (enExample) 2017-11-30
JP6333825B2 JP6333825B2 (ja) 2018-05-30

Family

ID=49293651

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015536065A Expired - Fee Related JP6333825B2 (ja) 2012-10-11 2013-10-01 インドリン

Country Status (10)

Country Link
US (1) US9403768B2 (enExample)
EP (1) EP2906535B1 (enExample)
JP (1) JP6333825B2 (enExample)
KR (1) KR20150065718A (enExample)
CN (1) CN104736519B (enExample)
CA (1) CA2884708A1 (enExample)
HK (1) HK1211025A1 (enExample)
MX (1) MX2015004465A (enExample)
RU (1) RU2015113959A (enExample)
WO (1) WO2014056755A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170062481A (ko) 2014-09-29 2017-06-07 뉴욕 인스티튜트 오브 테크놀로지 히스 전기도 교대맥을 기록하고 다양한 조건에 적용하는데 사용하기 위한 카테터
WO2016079527A1 (en) 2014-11-19 2016-05-26 Tetralogic Birinapant Uk Ltd Combination therapy
WO2016097773A1 (en) 2014-12-19 2016-06-23 Children's Cancer Institute Therapeutic iap antagonists for treating proliferative disorders
CN109152843A (zh) 2016-05-20 2019-01-04 豪夫迈·罗氏有限公司 Protac抗体缀合物及其使用方法
CA3148504A1 (en) 2019-08-08 2021-02-11 Institute For Cancer Research D/B/A/ The Research Institute Of Fox Chase Cancer Center Combination therapy for treatment of cancer
WO2023056069A1 (en) 2021-09-30 2023-04-06 Angiex, Inc. Degrader-antibody conjugates and methods of using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733995B1 (fr) 1995-05-09 1997-07-25 Inst Nat Sante Rech Med Inhibiteurs de l'inactivation de neuropeptides endogenes notamment la cholecystokinine, leurs procedes de preparation leur utilisation comme medicaments et procede de criblage de medicaments
CN1933847A (zh) * 2004-01-16 2007-03-21 密歇根大学董事会 Smac肽模拟物及其应用
CA2573644A1 (en) * 2004-07-12 2006-02-16 Idun Pharmaceuticals, Inc. Tetrapeptide analogs
CN101094833A (zh) * 2004-07-12 2007-12-26 伊邓药品公司 四肽类似物
NZ590550A (en) 2008-08-02 2013-05-31 Genentech Inc Inhibitors of Apoptosis (IAP) for treating cancer

Similar Documents

Publication Publication Date Title
JP2014511892A5 (enExample)
JP2014511891A5 (enExample)
JP2015537020A5 (enExample)
JP2013510120A5 (enExample)
JP2015505296A5 (enExample)
JP2013542261A5 (enExample)
JP2014506907A5 (enExample)
JP2013537203A5 (enExample)
JP2015024998A5 (enExample)
JP2014508804A5 (enExample)
JP2015534567A5 (enExample)
JP2009536620A5 (enExample)
JP2009504763A5 (enExample)
JP2015508103A5 (enExample)
JP2014526549A5 (enExample)
JP2010241830A5 (enExample)
JP2017537940A5 (enExample)
JP2017504635A5 (enExample)
JP2019524883A5 (enExample)
JP2017528467A5 (enExample)
JP2014511893A5 (enExample)
JP2012513416A5 (enExample)
JP2014500265A5 (enExample)
JP2013514980A5 (enExample)
JP2015521156A5 (enExample)